Celiac Disease Treatment Market Expansion to $0.94 Billion by 2029: Key Drivers and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the celiac disease treatment market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Celiac Disease Treatment Market Today And What Will It Reach By 2029?

The celiac disease treatment market has experienced robust expansion in recent years. It is anticipated to grow from $0.61 billion in 2024 to $0.66 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.8%. The increase observed historically can be attributed to a higher prevalence of celiac disease, greater awareness and improved diagnosis, a growing demand for non-dietary therapeutic choices, a strong array of innovative treatments in development, favorable regulatory policies, and increased financial contributions from pharmaceutical companies.

The celiac disease treatment market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $0.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the forecast period include the increasing global incidence of celiac disease, enhanced awareness and diagnosis, ongoing clinical trials exploring new treatments, a surge in demand for gluten-free options, favorable regulatory support for orphan diseases, and escalating healthcare spending. Key trends anticipated in the forecast period involve the adoption of innovative non-dietary therapies, progress in enzyme supplements, personalized medicine strategies, the creation of peptide-based immunotherapies, better diagnostic instruments, and developments in clinical trials.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

What Factors Are Boosting The Celiac Disease Treatment Market?

An anticipated factor contributing to the expansion of the celiac disease treatment market is the increasing incidence of diabetes. This chronic medical condition is characterized by the body’s inability to adequately manage blood sugar or glucose levels. The growing occurrence of diabetes stems from common dietary management requirements, given that both diabetes and celiac disease necessitate meticulous regulation of food consumption for blood sugar control and complication avoidance. Celiac disease treatment offers benefits for diabetes through its encouragement of a gluten-free diet, which in turn can enhance general digestive well-being and nutrient uptake. This approach facilitates superior blood sugar management and lessens complications for individuals dealing with both ailments. As an illustration, figures from June 2024, provided by the National Health Service, a UK-based government department, reveal that approximately 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes in 2023. This represents an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the escalating prevalence of diabetes acts as a significant impetus for the growth of the celiac disease treatment market.

How Is The Celiac Disease Treatment Market Categorized By Application, Type, And Region?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

How Are Technological Trends Affecting The Celiac Disease Treatment Market Growth?

Leading firms within the celiac disease treatment market are prioritizing the creation of oral treatments, particularly small molecule therapies. These aim to deliver specific relief by inhibiting immune reactions to gluten, enhancing patient compliance, and presenting options beyond rigorous gluten-free regimens. Small molecule therapies constitute minute pharmaceutical agents capable of readily entering cells to precisely target and address disease-triggering proteins or enzymes. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology company, introduced IMU-856. IMU-856 functions as a small molecule that elevates endogenous glucagon-like peptide-1 (GLP-1) levels, thereby assisting in the enhancement of intestinal barrier function in individuals with celiac disease. Furthermore, it boosts nutrient absorption and eases symptoms without suppressing immune system activity.

Who Are The Global Leaders Steering The Celiac Disease Treatment Market Forward?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2025, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Granulocyte Colony Stimulating Factors Market 2025

https://www.thebusinessresearchcompany.com/report/granulocyte-colony-stimulating-factors-market

Autoimmune Disease Diagnosis Market 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795